GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
157 hedge funds and large institutions have $1.71B invested in Global Blood Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 49 increasing their positions, 51 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 136 → 157 (+21)
4% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 51
Holders
157
Holding in Top 10
9
Calls
$49.5M
Puts
$29.1M
Top Buyers
| 1 | +$63.5M | |
| 2 | +$49.7M | |
| 3 | +$31.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$28.2M |
| 5 |
PA
Perceptive Advisors
New York
|
+$24.6M |
Top Sellers
| 1 | -$70.7M | |
| 2 | -$13.7M | |
| 3 | -$13.5M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.4M |
| 5 |
O
OrbiMed
New York
|
-$9.28M |